CNMD Q1 2026 Earnings Adjusted EPS Surpasses Consensus Shares Edge Higher Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development SVV Q1 2026 Earnings Narrow EPS Miss Amid Positive Market Response MTX Q1 2026 Earnings EPS Surprises to the Upside as Earnings Beat Estimates ATRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline FGBI Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Gains 4